Absorption, Distribution, Metabolism, and Elimination (ADME) constitute the fundamental pharmacokinetic processes that govern the fate of drugs within the human body.
Absorption initiates the journey as the drug enters the bloodstream, influenced by factors like formulation and administration route.
Distribution guides the drug to target tissues, determined by blood flow, permeability, and binding characteristics.
Metabolism, predominantly in the liver, transforms the drug into metabolites, facilitating elimination and enhancing water solubility.
Elimination, occurring through renal excretion, hepatic excretion, and other routes, marks the final phase.
Bioavailability, half-life, and first-pass metabolism are pivotal parameters influencing drug efficacy, dosage frequency, and duration of action. The intricate interplay of these processes underscores the concept of pharmacokinetics, essential for comprehending drug behavior. Variability in individual factors, drug interactions, and the emergence of adverse reactions further emphasize the need for meticulous consideration of ADME in drug development and clinical application. Prodrugs and therapeutic drug monitoring underscore the innovative approaches to drug design and optimization, ensuring both efficacy and safety. Regulatory bodies demand a thorough understanding of ADME parameters during drug evaluation, emphasizing its critical role in shaping pharmaceutical landscapes.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation